Table 3.
Overall | White (non-Hispanic) | Black (non-Hispanic) | Mexican-American /Other Hispanic |
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
APRI | |||||||||||
Normal | Abnormalc | Normal | Abnormal | Normal | Abnormal | Normal | Abnormal | ||||
Model 1a | 0.96 | 0.75 | 0.97 | 0.69 | 1.00 | 0.86 | 0.95 | 0.89 | |||
(0.94,0.99) | (0.64,0.88) | (0.94,1.00) | (0.55,0.86) | (0.95,1.06) | (0.66,1.12) | (0.89,1.01) | (0.72,1.09) | ||||
Model 2b | 0.96 | 0.76 | 0.97 | 0.71 | 1.00 | 0.82 | 0.95 | 0.9 | |||
(0.94,0.99) | (0.64,0.89) | (0.94,1.00) | (0.57,0.89) | (0.95,1.07) | (0.63,1.07) | (0.89,1.01) | (0.72,1.13) | ||||
FIB4 | |||||||||||
Normal | Abnormal | Normal | Abnormal | Normal | Abnormal | Normal | Abnormal | ||||
Model 1 | 0.96 | 0.81 | 0.97 | 0.79 | 1.00 | 0.92 | 0.95 | 0.88 | |||
(0.94,0.99) | (0.70,0.93) | (0.94,1.00) | (0.66,0.95) | (0.94,1.06) | (0.72,1.18) | (0.89,1.01) | (0.67,1.15) | ||||
Model 2 | 0.96 | 0.80 | 0.97 | 0.79 | 1.00 | 0.89 | 0.95 | 0.88 | |||
(0.94,0.99) | (0.70,0.93) | (0.94,1.00) | (0.66,0.95) | (0.95,1.06) | (0.69,1.13) | (0.89,1.01) | (0.66,1.17) | ||||
NFS | |||||||||||
Normal | Abnormal | Normal | Abnormal | Normal | Abnormal | Normal | Abnormal | ||||
Model 1 | 0.97 | 0.77 | 0.97 | 0.78 | 1.00 | 0.98 | 0.95 | 0.82 | |||
(0.95,1.00) | (0.71,0.84) | (0.94,1.00) | (0.71,0.86) | (0.94,1.06) | (0.79,1.22) | (0.89,1.01) | (0.66,1.01) | ||||
Model 2 | 0.97 | 0.83 | 0.97 | 0.85 | 1.00 | 1.02 | 0.95 | 0.84 | |||
(0.94,0.99) | (0.77,0.90) | (0.94,1.00) | (0.77,0.94) | (0.94,1.06) | (0.81,1.29) | (0.89,1.01) | (0.69,1.04) |
Model 1 adjusted for age and race, numbers with bold font implies p<0.05;
Model 2 adjusted for the age, race, BMI category, diabetes status, alcohol drinking status and smoking status;
Cutpoint for abnormal liver fibrosis equates to advanced fibrosis (APRI >1, FIB-4 >2.67 and NFS >0.676).